Delivery Order SPE2DB24D8002-SPE2DB25FJPBM
Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,439.71, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 6, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through the DLA....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $16,948.76 contract is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The contract has a ceiling value of $1,384.04 and an ultimate completion date of November 29, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) identified as SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $18,462.43 firm fixed-price contract is for the delivery of 4566847986 LOSARTAN-HCTZ 100-25 MG TAB 90S to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of January 7, 2025 and is not a set-aside. Dakota Drug, Inc. is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a firm fixed price of $22,937.69 and a period of performance through March 5, 2025. This award is not designated as a set-aside contract. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $9,399.10 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Losartan-HCTZ 100-25 mg tablets in quantities of 90. The contract, awarded on May 27, 2025, with an ultimate completion date of May 28, 2025, utilizes a firm fixed price delivery order structure with no set-aside designation. This award represents a single transaction under Dakota Drug's larger Indefinite Delivery Contract...
- This federal contract award, valued at $14,626.01, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order for the delivery of 90-count bottles of Losartan-HCTZ 100-12.5 mg tablets. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 for the provision of a...
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566854010 - LOSARTAN-HCTZ 100-25 MG TAB 90S. The contract has a ceiling value of $1,454.42 and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
- The Defense Logistics Agency awarded a $32.1K firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. The award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a single delivery order under Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. This...